Cited 0 times in
Transcriptomic profiling of intermediate cell carcinoma of the liver
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jang, B | - |
dc.contributor.author | Kwon, SM | - |
dc.contributor.author | Kim, JH | - |
dc.contributor.author | Kim, JM | - |
dc.contributor.author | Chung, T | - |
dc.contributor.author | Yoo, JE | - |
dc.contributor.author | Kim, H | - |
dc.contributor.author | Calderaro, J | - |
dc.contributor.author | Woo, HG | - |
dc.contributor.author | Park, YN | - |
dc.date.accessioned | 2024-09-27T00:19:59Z | - |
dc.date.available | 2024-09-27T00:19:59Z | - |
dc.date.issued | 2024 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/32841 | - |
dc.description.abstract | Background: Intermediate cell carcinoma (Int-CA) is a rare and enigmatic primary liver cancer characterized by uniform tumor cells exhibiting mixed features of both HCC and intrahepatic cholangiocarcinoma. Despite the unique pathological features of int-CA, its molecular characteristics remain unclear yet. Methods: RNA sequencing and whole genome sequencing profiling were performed on int-CA tumors and compared with those of HCC and intrahepatic cholangiocarcinoma. Results: Int-CAs unveiled a distinct and intermediate transcriptomic feature that is strikingly different from both HCC and intrahepatic cholangiocarcinoma. The marked abundance of splicing events leading to intron retention emerged as a signature feature of int-CA, along with a prominent expression of Notch signaling. Further exploration revealed that METTL16 was suppressed within int-CA, showing a DNA copy number–dependent transcriptional deregulation. Notably, experimental investigations confirmed that METTL16 suppression facilitated invasive tumor characteristics through the activation of the Notch signaling cascade. Conclusions: Our results provide a molecular landscape of int-CA featured by METTL16 suppression and frequent intron retention events, which may play pivotal roles in the acquisition of the aggressive phenotype of Int-CA. | - |
dc.language.iso | en | - |
dc.subject.MESH | Bile Duct Neoplasms | - |
dc.subject.MESH | Carcinoma, Hepatocellular | - |
dc.subject.MESH | Cholangiocarcinoma | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Gene Expression Profiling | - |
dc.subject.MESH | Gene Expression Regulation, Neoplastic | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Liver Neoplasms | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Methyltransferases | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Signal Transduction | - |
dc.subject.MESH | Transcriptome | - |
dc.title | Transcriptomic profiling of intermediate cell carcinoma of the liver | - |
dc.type | Article | - |
dc.identifier.pmid | 39101773 | - |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11299988 | - |
dc.contributor.affiliatedAuthor | Woo, HG | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1097/HC9.0000000000000505 | - |
dc.citation.title | Hepatology communications | - |
dc.citation.volume | 8 | - |
dc.citation.number | 8 | - |
dc.citation.date | 2024 | - |
dc.citation.startPage | e0505 | - |
dc.citation.endPage | e0505 | - |
dc.identifier.bibliographicCitation | Hepatology communications, 8(8). : e0505-e0505, 2024 | - |
dc.identifier.eissn | 2471-254X | - |
dc.relation.journalid | J02471254X | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.